Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.074 | 0.7 |